Rujin Ji

5PUBLICATIONS
22CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Nanotoxicology, health and safetyBiogeography and phylogeographyMedical infection agents (incl. prions)Medical bacteriology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Sep 28, 2026
Model-Informed Ceftazidime-Avibactam Dosing Stratified by Renal Function and Renal Replacement Therapy Status in Critically Ill Patients: A Prospective Population Pharmacokinetic and Monte Carlo Simulation Study.

|Mar 02, 2026
Time to Awaken a Forgotten Antibacterial Agent: A 10-year Nationwide Surveillance of Latamoxef Resistance in China Based on 46,716 Isolates and Establishment of Tentative Epidemiological Cut-Off Values.

Pan Chen, Erjia Zhang, Yingying Ma

|Apr 14, 2025
Genomic epidemiology and phylodynamics of Acinetobacter baumannii bloodstream isolates in China.

Qixia Luo, Mengru Chang, Ping Lu

|Jul 15, 2021
Evaluation of Ceftazidime/Avibactam Administration in Enterobacteriaceae and Pseudomonas aeruginosa Bloodstream Infections by Monte Carlo Simulation.

Yuanyuan Dai, Wenjiao Chang, Xin Zhou

|Jun 25, 2021
Optimal Empiric Polymyxin B Treatment of Patients Infected with Gram-Negative Organisms Detected Using a Blood Antimicrobial Surveillance Network in China.

Xingbing Wu, Chen Huang, Hui Wang

Pageof 1

Frequent Collaborators

4 joint publications

Yunbo Chen

4 joint publications

Chaoqun Ying

3 joint publications

Zhiying Liu

1 joint publications

Juan Hu